Helen S. Kim
InvestorSenior Managing Director at Vida Ventures
About
Helen S. Kim offers a deep operator's perspective—having led two C‑suite biotech M&A exits (Kosan→Bristol‑Myers Squibb, Kite→Gilead) and CEO roles across big pharma and emerging biotech—bridging founders, strategics, and investors.
Invests in
BiotechHealthtech
Deals · 3
RECODE THERAPEUTICS, INC.Board seat
via Vida Ventures · filed Oct 2025 · $29.4M raise
Aktis OncologyBoard seat
via Vida Ventures · filed Oct 2024 · $175M raise
IconOVir BioBoard seat
via Vida Ventures · filed Jun 2024 · $20.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Vida Ventures
Alessandro Giacometti
Vice President, Head of Investor Relations at Vida Ventures
Alex Loftis
Principal at Vida Ventures
Alex Mejia
Executive Services Manager at Vida Ventures
Alex Shen
Director of Operations at Vida Ventures
Andy Kadlec
Senior Associate at Vida Ventures
Anita Keenan
Executive Assistant at Vida Ventures
Arie Belldegrun
Founder and Senior Managing Director at Vida Ventures
Arjun Goyal
Managing Director at Vida Ventures